COVID-19 vaccination roll-outs in eleven small countries within the WHO European region; Lessons learned

The development and administration of COVID-19 vaccines has been an essential element in controlling the COVID-19 pandemic. However, countries worldwide have faced challenges in planning and implementing vaccination strategies. The aim of the current paper is to describe the situation faced by small...

Full description

Saved in:
Bibliographic Details
Main Authors: Katie Palmer (Author), Leda Nemer (Author), Siddhartha Sankar Datta (Author), Bettina Maria Menne (Author)
Format: Book
Published: Frontiers Media S.A., 2022-08-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_df0b2d16a056443d8366fb4358cb9795
042 |a dc 
100 1 0 |a Katie Palmer  |e author 
700 1 0 |a Leda Nemer  |e author 
700 1 0 |a Siddhartha Sankar Datta  |e author 
700 1 0 |a Bettina Maria Menne  |e author 
245 0 0 |a COVID-19 vaccination roll-outs in eleven small countries within the WHO European region; Lessons learned 
260 |b Frontiers Media S.A.,   |c 2022-08-01T00:00:00Z. 
500 |a 2296-2565 
500 |a 10.3389/fpubh.2022.959227 
520 |a The development and administration of COVID-19 vaccines has been an essential element in controlling the COVID-19 pandemic. However, countries worldwide have faced challenges in planning and implementing vaccination strategies. The aim of the current paper is to describe the situation faced by small countries in the WHO European Region in implementing their national vaccination strategies during the first stages of the planned roll-out (up to May 2021). This paper uses information from the WHO Small Countries Initiative (SCI), which includes a network of 11 countries with populations of ≤ 2 million (Andorra, Cyprus, Estonia, Iceland, Latvia, Luxembourg, Malta, Monaco, Montenegro, San Marino, and Slovenia). The SCI countries faced many challenges including: a lack of appropriate vaccination centers, adequate workforce, and registration/booking systems to cope with the unprecedented vaccine storage and administration demands; difficulties for high-risk groups (e.g., older individuals and those with health problems or cognitive impairment) to access vaccination sites or use digital registration/booking systems; vaccine wastage due to canceled appointments; and inequalities in vaccine uptake. Innovative programmatic interventions were implemented to facilitate the vaccination uptake of the populations such as: the creation of non-medical vaccination sites and mobile vaccination units; on-site vaccination of people in long-term residential facilities and long-term medical wards; diversifying health workforce like redeployment of healthcare professionals and use of medical students and retired medical professionals; campaigns with clear information to the general public (in multiple languages where necessary) both offline and online; use of digital registration/booking systems and alternative (non-digital) registration/booking systems for relevant individuals; and administration of excess vaccine doses to non-priority groups to avoid wastage. 
546 |a EN 
690 |a COVID-19 
690 |a WHO European Region 
690 |a vaccines 
690 |a immunization 
690 |a prevention 
690 |a vaccine strategies 
690 |a Public aspects of medicine 
690 |a RA1-1270 
655 7 |a article  |2 local 
786 0 |n Frontiers in Public Health, Vol 10 (2022) 
787 0 |n https://www.frontiersin.org/articles/10.3389/fpubh.2022.959227/full 
787 0 |n https://doaj.org/toc/2296-2565 
856 4 1 |u https://doaj.org/article/df0b2d16a056443d8366fb4358cb9795  |z Connect to this object online.